ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 526

Endochondral Bone Formation and Advanced Enthesitis Are Key Features Of Proteoglycan Induced Spondylitis Mouse Model Of Ankylosing Spondylitis

Gethin P Thomas1, Hsu-Wen Tseng2, Allison Pettit3,4, Tibor T. Glant5, Allan McRae2 and Matthew A. Brown6, 1Translational Reserch Institute, University of Queensland Diamantina Institute, Woolloongabba, Australia, 2University of Queensland Diamantina Institute, Woolloongabba, Australia, 3Mater Research, Woolloongabba, Australia, 4University of Queensland Centre for Clinical Research, Herston, Australia, 5Orthopedic Surgery, Rush University Medical Center, Chicago, IL, 6University of Queensland Diamantina Institute, Brisbane, Australia

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Animal models, ankylosing spondylitis (AS) and cartilage, Bone

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis: Pathogenesis, Etiology, Animal Models I

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Transition from an initial inflammatory phase to the disabling osteoproliferative phase in ankylosing spondylitis (AS) is very poorly understood. Elucidation of the mechanisms underlying this disease progression would identify new therapeutic targets and strategies.

The proteoglycan induced spondylitis (PGISp) mouse mirrors human AS disease progression with an initial inflammatory insult resulting in excessive osteoproliferation and frequently joint fusion. We therefore sought to model human AS progression by extensively characterizing the morphological, cellular and molecular changes over a time course of disease in the PGISp mouse

Methods:

Spine and spleen cells from PGISp and control mice were analysed over a 6 month timecourse. The histological features were described using a novel scoring regime including many features seen in human AS, such as inflammation, disc destruction, bone erosion, excess tissue formation (mesenchymal tissue expansion or fibrocartilage formation) around IVDs as well as ectopic tissue formation in the longitudinal ligament. Immunohistochemistry for collagens type I, II and X was used to delineate the nature of the excessive tissue formation seen in this model. Key factors involved both at the joint and systemic levels were analyzed using FACS and qPCR.

Results:

Initial inflammation at the periphery of the discs was seen from week 6 which corresponded with an upregulation in expression of inflammatory markers such as TNFa, MMP3 and MMP13. Inflammation progressed over the next 4 weeks with massive inflammatory cell infiltration, disc destruction and erosion of bone and growth plate cartilage. A switch to an “anabolic” phase was then evident with upregulation of collagen II and X, and a corresponding decrease in inflammatory/catabolic genes. An extensive fibrocartilaginous matrix is laid down (excessive tissue formation) by large numbers of chondrocytes.  One key feature of severely affected vertebrae is the appearance of ectopic chondrocytes laying down a cartilaginous matrix between the vertebral joints possibly corresponding to entheseal junctions. Such a feature potentially supports a role for endochondral ossification in the disease progression in this model.

Conclusion:

The PGISp mouse model displays many features of AS. Of key interest is the initial inflammation giving way to extensive tissue formation. The presence of ectopic chondrocytes indicative of endochondral ossification at the entheses is a key insight into the disease process that can be translated to the human condition.


Disclosure:

G. P. Thomas,
None;

H. W. Tseng,
None;

A. Pettit,
None;

T. T. Glant,
None;

A. McRae,
None;

M. A. Brown,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/endochondral-bone-formation-and-advanced-enthesitis-are-key-features-of-proteoglycan-induced-spondylitis-mouse-model-of-ankylosing-spondylitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology